Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
3,4 Dichloroisocoumarin | 51050-59-0 | sc-3502 | 5 mg | $246.00 | 8 | |
3,4-Dichloroisocoumarin is a distinctive compound known for its selective reactivity in biochemical pathways. Its structure allows for specific interactions with serine proteases, influencing enzymatic activity through competitive inhibition. The presence of chlorine substituents enhances its electrophilic character, facilitating nucleophilic attack and subsequent reaction kinetics. This compound's unique conformation also contributes to its ability to modulate protein interactions, impacting cellular processes. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $50.00 $120.00 $420.00 $834.00 $1836.00 $4896.00 | 33 | |
Serine protease inhibitor; could inhibit Granzyme A by binding to its active site. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $80.00 $300.00 | 4 | |
Nafamostat mesylate is a synthetic compound characterized by its ability to interact with serine proteases, particularly granzyme A. Its unique structure enables it to form stable complexes with target enzymes, altering their activity through non-covalent interactions. The compound exhibits rapid reaction kinetics, allowing for efficient modulation of proteolytic pathways. Additionally, its specific molecular configuration enhances selectivity, influencing downstream signaling cascades in cellular environments. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
Serine protease inhibitor; might block Granzyme A's active site, reducing its proteolytic activity. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $165.00 $214.00 $396.00 $617.00 $4804.00 | 19 | |
Broad-spectrum metalloproteinase inhibitor; could indirectly affect Granzyme A's activation or function. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $275.00 $928.00 $1543.00 | 14 | |
Irreversible cysteine protease inhibitor; might indirectly influence Granzyme A's activity. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $110.00 $400.00 $1615.00 | 51 | |
Kunitz-type serine protease inhibitor; could bind to Granzyme A, inhibiting its function. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $72.00 $145.00 $265.00 $489.00 $1399.00 $99.00 | 19 | |
Inhibits serine and cysteine proteases; might reduce Granzyme A's proteolytic activity. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $74.00 | 256 | |
Broad-spectrum caspase inhibitor; might indirectly inhibit pathways activated by Granzyme A. | ||||||
L-Lysine | 56-87-1 | sc-207804 sc-207804A sc-207804B | 25 g 100 g 1 kg | $93.00 $258.00 $519.00 | ||
Specific inhibitor of trypsin-like serine proteases; could inhibit Granzyme A activity. |